Irisbond
Financials
Estimates*
EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | <1m | <1m | <1m | 1.2m | 1.5m | 2.1m | 2.6m |
% growth | 121 % | (24 %) | 55 % | 41 % | 25 % | 42 % | 27 % |
EBITDA | <1m | (<1m) | (<1m) | <1m | <1m | - | - |
% EBITDA margin | 25 % | (14 %) | (10 %) | 24 % | 31 % | - | - |
Profit | <1m | (<1m) | (<1m) | <1m | <1m | - | - |
% profit margin | 18 % | (35 %) | (26 %) | 6 % | 7 % | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | N/A | Spinout | |
€370k | - | ||
* | €300k | Seed | |
N/A | Support Program | ||
* | €1.2m | Early VC | |
€17.5k | Grant | ||
€17.5k | Grant | ||
N/A | Support Program | ||
* | €2.0m | Late VC | |
* | €400k Valuation: €10.0m | Late VC | |
Total Funding | €4.3m |
Recent News about Irisbond
EditIrisbond operates in the assistive technology market, specializing in advanced eye-tracking solutions. The company develops and sells products that enable individuals with disabilities to communicate and interact with digital devices using only their eyes. Irisbond's primary clients include healthcare providers, educational institutions, and individuals with mobility impairments. The business model revolves around the sale of hardware and software solutions, as well as offering support and training services. Revenue is generated through direct sales, partnerships, and licensing agreements. The company leverages cutting-edge technology to improve the quality of life for its users, making digital interaction more accessible and inclusive.
Keywords: eye-tracking, assistive technology, disabilities, communication, accessibility, healthcare, education, mobility impairments, hardware, software.